APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 64 filers reported holding APTINYX INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,193 | +104.8% | 27,973 | +154.3% | 0.00% | – |
| Q3 2022 | $4,000 | -76.5% | 11,000 | -64.4% | 0.00% | – |
| Q2 2022 | $17,000 | -85.1% | 30,900 | -38.5% | 0.00% | – |
| Q1 2022 | $114,000 | -37.7% | 50,240 | -26.3% | 0.00% | – |
| Q4 2021 | $183,000 | -26.8% | 68,173 | -36.2% | 0.00% | – |
| Q3 2021 | $250,000 | -32.6% | 106,809 | -18.5% | 0.00% | – |
| Q2 2021 | $371,000 | +401.4% | 131,042 | +430.5% | 0.00% | – |
| Q1 2021 | $74,000 | -81.5% | 24,700 | -78.6% | 0.00% | – |
| Q4 2020 | $400,000 | +247.8% | 115,536 | +319.5% | 0.00% | – |
| Q2 2020 | $115,000 | -55.1% | 27,541 | -62.5% | 0.00% | – |
| Q3 2019 | $256,000 | -23.8% | 73,355 | -27.1% | 0.00% | – |
| Q2 2019 | $336,000 | +57.7% | 100,680 | +91.4% | 0.00% | – |
| Q1 2019 | $213,000 | -94.4% | 52,606 | -77.2% | 0.00% | -100.0% |
| Q4 2018 | $3,814,000 | -58.1% | 230,584 | -26.6% | 0.00% | -50.0% |
| Q3 2018 | $9,093,000 | +296.6% | 314,005 | +231.1% | 0.00% | +300.0% |
| Q2 2018 | $2,293,000 | – | 94,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 5,395,996 | $1,997,000 | 0.55% |
| Bain Capital Life Sciences Investors, LLC | 8,891,758 | $3,273,000 | 0.39% |
| Artal Group S.A. | 6,116,493 | $2,251,000 | 0.10% |
| Frazier Life Sciences Management, L.P. | 1,883,244 | $693,000 | 0.05% |
| NORTHWESTERN UNIVERSITY | 109,280 | $40,000 | 0.04% |
| RA Capital Management | 1,954,698 | $720,000 | 0.02% |
| Meridian Wealth Management, LLC | 192,000 | $71,000 | 0.01% |
| HBK Sorce Advisory LLC | 26,000 | $26,000 | 0.00% |
| Point72 Asset Management, L.P. | 410,416 | $151,000 | 0.00% |
| Virtu Financial LLC | 23,806 | $9,000 | 0.00% |